Skip to main content
. 2023 Nov 9;11:1302594. doi: 10.3389/fbioe.2023.1302594

TABLE 1.

Optimized concentration of polymers and drug solution for electrospinning.

Formulation PVA (%) PVP (%) Ratio HA ALN
PVA-PVP-HA 8 12 50/50 2% -
PVA-PVP-ALN 8 12 50/50 - 2%
PVA-PVP-ALN-HA 8 12 50/50 2% 2%